Next Article in Journal
Search of Potential Vaccine Candidates against Trueperella pyogenes Infections through Proteomic and Bioinformatic Analysis
Next Article in Special Issue
Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
Previous Article in Journal
The African Swine Fever Virus (ASFV) Topoisomerase II as a Target for Viral Prevention and Control
Previous Article in Special Issue
Innate Lymphocyte Th1 and Th17 Responses in Elderly Hospitalised Patients with Infection and Sepsis
Open AccessReview

Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants

Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, 28220 Madrid, Spain
Authors to whom correspondence should be addressed.
Both authors contributed equally to this study.
Vaccines 2020, 8(2), 313;
Received: 1 June 2020 / Revised: 12 June 2020 / Accepted: 16 June 2020 / Published: 17 June 2020
(This article belongs to the Special Issue Research on Innate Immunity and Inflammation)
Despite successful treatments, hepatitis C virus (HCV) infections continue to be a significant world health problem. High treatment costs, the high number of undiagnosed individuals, and the difficulty to access to treatment, particularly in marginalized susceptible populations, make it improbable to achieve the global control of the virus in the absence of an effective preventive vaccine. Current vaccine development is mostly focused on weakly immunogenic subunits, such as surface glycoproteins or non-structural proteins, in the case of HCV. Adjuvants are critical components of vaccine formulations that increase immunogenic performance. As we learn more information about how adjuvants work, it is becoming clear that proper stimulation of innate immunity is crucial to achieving a successful immunization. Several hepatic cell types participate in the early innate immune response and the subsequent inflammation and activation of the adaptive response, principally hepatocytes, and antigen-presenting cells (Kupffer cells, and dendritic cells). Innate pattern recognition receptors on these cells, mainly toll-like receptors, are targets for new promising adjuvants. Moreover, complex adjuvants that stimulate different components of the innate immunity are showing encouraging results and are being incorporated in current vaccines. Recent studies on HCV-vaccine adjuvants have shown that the induction of a strong T- and B-cell immune response might be enhanced by choosing the right adjuvant. View Full-Text
Keywords: HCV; vaccine; adjuvant; innate immune response; PRRs HCV; vaccine; adjuvant; innate immune response; PRRs
Show Figures

Figure 1

MDPI and ACS Style

Sepulveda-Crespo, D.; Resino, S.; Martinez, I. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants. Vaccines 2020, 8, 313.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop